Home >> Blog >> Niva Bupa Health Insurance IPO: Price & GMP
Niva Bupa Health Insurance IPO: Price & GMP
Table of Contents
- Niva Bupa Health Insurance IPO-Complete Overview
- Niva Bupa Health Insurance IPO Details
- Niva Bupa Health Insurance: Product Portfolio
- Company Financial
- The Objective of The Issue
- Peers of Niva Bupa Health Insurance Ltd.
- Evaluation
- IPO's Strengths
- IPO’s Weaknesses
- Niva Bupa IPO GMP
- Niva Bupa Health Insurance IPO Details
- Promoters and Management of Niva Bupa Health Insurance Ltd.
- Niva Bupa Health Insurance IPO Lead Managers
- Dividend Policy
- Conclusion
Niva Bupa Health Insurance IPO-Complete Overview
Niva Bupa Health Insurance IPO a Mainboard IPO is a book-built issue of Rs.2,200 crore (29,72,97,297 Shares) by Niva Bupa Health Insurance Ltd. was established in 2008 as a collaboration between Bupa Group and Fettle Tone LLP. It sells health insurance.
This company introduces its full suite through its complete health ecosystem and service capabilities on the website for the Niva Bupa Health website. It is also available in a mobile application.
The company's offerings can be generally divided into:
-
Retail goods are intended for both families and individuals.
-
Collective goods aimed at employers and workers.
-
The company had 14.73 million active life insured as of March 31, 2024.
-
The corporation operates in 22 Indian states and 4 UTs as of March 31, 2024.
-
The total GWP increased at a CAGR of 41.27% between FY 2022 and FY 2024, whereas GWP from retail grew by 33.41%.
This new IPO is to be launched on 07 November 2024, and the initial public offering of this upcoming IPO will end on 11 November 2024.
Niva Bupa Health Insurance IPO Details
The Rs.2,200 crore Niva Bupa Health IPO comprises a fresh Issue of 10.81 crore Shares (Rs.800 Cr) and an offer for sale (OFS) of 18.92 crore Shares (Rs.1400 Cr).
The Niva Bupa IPO date is from 07 November to November 11, 2024. The IPO listing date is on Thursday, November 14, 2024, and it will be listed at BSE and NSE. Niva Bupa IPO price band is Rs.70 to Rs.74 for each Share.
Niva Bupa IPO Shareholders' quota
This Insurance IPO's shareholder quota is 10% allocated to retail investors, 75% to institutional investors (QIB), and 15% to non-institutional investors (NII).
If You want to apply for the IPO, Click Here to Open a Demat Account.
Niva Bupa Health Insurance: Product Portfolio
Company Financial
The company’s revenue grew by 44.05% and PAT increased by 552.73% between FYs ended 31 March 2024 and 31 March 2023.
(Amount in Crore)
Period |
30 Jun 2024 |
31 Mar 2024 |
31 Mar 2023 |
Total Assets |
6,542.06 |
6,191.87 |
3,876.57 |
Total Revenue |
1,124.90 |
4,118.63 |
2,859.24 |
PAT |
-18.82 |
81.85 |
12.54 |
Net Worth |
2,031.77 |
2,049.59 |
831.12 |
Total Reserves & Surplus |
1,282.44 |
1,282.02 |
334.26 |
Borrowings |
250 |
250 |
250 |
Revenue Bifurcation
Below is the revenue breakdown for various activities.
(Amount in million)
Net Cash Flow In Various Activities |
30 Jun 2024 |
FY2024 |
FY2023 |
Net Cash Flow Operating Activities |
715.58 |
958.46 |
8,125.25 |
Net Cash Flow Investing Activities |
-1,167.19 |
-3,273.64 |
-18,815.86 |
Net Cash Flow Financing Activities |
36.05 |
2,051.65 |
11,100.18 |
Customers-wise Revenue Bifurcation
(Values in millions)
Particular |
30 Jun 2024 |
FY2024 |
FY2023 |
Retail |
10,169.12 |
39,349.50 |
30,492.85 |
Group |
4,472.64 |
16,726.24 |
10,237.45 |
Segment-wise Revenue Bifurcation
(Values in millions)
Particular |
30 Jun 2024 |
FY2024 |
FY2023 |
Health |
14,303.84 |
54,944.28 |
39,873.59 |
Personal Accident |
271.80 |
926.76 |
800.41 |
Travel |
66.12 |
204.70 |
56.31 |
Revenue Bifurcation
(Values in millions)
Particular |
30 Jun 2024 |
FY2024 |
FY2023 |
Individual |
463.04 |
2,015.67 |
2,184.58 |
Family |
9,442.71 |
36,381.67 |
27,512.82 |
Geography-wise Revenue Bifurcation
The Objective of The Issue
The company desires to use the Net Proceeds from the Issue to fulfill its following goals:
-
Expansion of its capital base to boost levels of solvency.
-
Corporate Purposes.
Peers of Niva Bupa Health Insurance Ltd.
Company Name |
Face Value (Rs.) |
EPS (Rs.) |
P/E (x) |
Star Health and Allied Insurance Company Limited |
10 |
14.48 |
36.97 |
ICICI Lombard General Insurance Company Ltd. |
10 |
39.03 |
45.92 |
The New India Assurance Company Ltd. |
5 |
6.77 |
35.23 |
Evaluation
Niva IPO price is between Rs.70 to Rs.74 for each Share.
Evaluation of P/E Ratio
Considering the period of FY 2024, with an EPS of Rs.0.51 from the last year, the resulting P/E ratio is 145.09x.
Considering the weighted EPS of Rs.0.05 for the last three years, the P/E ratio is 1480x.
Comparative Analysis with Listed Peers
The average P/E Ratio of the industry is 38.60x.
Particulars |
P/E Ratio (x) |
Highest |
48.91 |
Lowest |
28.62 |
Average |
38.60 |
IPO's Strengths
-
Granular retail health insurer that prioritizes profitability, capital efficiency, and strong GWP growth.
-
Its wide range of products for clients is supported by its history of developing innovative products.
-
An automated, technology-driven approach to customer service.
-
The parent company and brand of Bupa, which is linked to health insurance and healthcare.
-
Its expertise in claims and provider management.
-
Pan-India distribution that is multi-channel diverse and empowers distribution partners through technology.
IPO’s Weaknesses
-
The ability of the business to control underwriting risks and set product prices effectively determines how profitable it will be.
-
The health insurance sector accounts for a sizable amount of business.
-
The business is subject to stringent oversight and regulatory examinations.
-
The company depends on its intermediary channels of distribution.
-
The company has lost money as a loss.
Niva Bupa IPO GMP
Niva Bupa Health Insurance IPO GMP today is Rs.0 as of 04 November 2024. With a price of Rs.74 per Share, the estimated IPO listing price is Rs.74 when writing this information
Niva Bupa Health Insurance IPO Timetable (Tentative)
The IPO open date is from November 07 to November 11, 2024, with IPO allotment on November 12, 2024, refund initiation on November 13, 2024, and listing on Monday, November 14, 2024.
Events |
Date |
IPO Opening Date |
November 07, 2024 |
IPO Closing Date |
November 11, 2024 |
IPO Allotment Date |
November 12, 2024 |
Refund Initiation |
November 13, 2024 |
IPO Listing Date |
November 14, 2024 |
Niva Bupa Health Insurance IPO Details
The IPO with a face value of Rs.10 per Share offers a total issue size of 297,297,297 Shares and will be listed at BSE and NSE.
IPO Opening & Closing date |
November 07, 2024 to November 11, 2024 |
Face Value |
Rs.10 per Share |
Issue Price |
Rs.70 to Rs.74 |
Lot Size |
200 Shares |
Issue Size |
29,72,97,297 Shares (Rs.2200 Cr) |
Offer for Sale |
189,189,189 Shares (Rs.1400 Cr) |
Fresh Issue |
108,108,108 Shares (Rs.800 Cr) |
Listing At |
BSE, NSE |
Issue Type |
Book Built Issue IPO |
Registrar |
Kfin Technologies Limited |
Niva Bupa Health Insurance IPO Lot Size
The IPO allows retail investors to invest in a minimum and maximum of 1 Lot (200 Shares) amounting to Rs.14800 and 13 Lots (2600 Shares) amounting to Rs.1,92,400 respectively, while for HNI investors, the minimum Lot is 14 (2800 Shares) amounting to Rs.2,07,200.
Minimum Lot Investment (Retail) |
1 Lot |
Maximum Lot Investment (Retail) |
13 Lots |
S-HNI (Minimum) |
14 Lots |
S-HNI (Maximum) |
67 Lots |
B-HNI (Minimum) |
68 Lots |
Niva Bupa Health Insurance IPO Reservation
Institutional Share Portion |
75% |
Retail Investors Share Portion |
10% |
Non-Institutional Shares Portion |
15% |
Promoters and Management of Niva Bupa Health Insurance Ltd.
-
Bupa Singapore Holdings Pte. Ltd.
-
Bupa Investments Overseas Limited.
Pre-Issue Promoter Shareholding |
62.27% |
Post-Issue Promoter Shareholding |
- |
Niva Bupa Health Insurance IPO Lead Managers
-
ICICI Securities Limited
-
Morgan Stanley India Company Pvt Ltd.
-
Kotak Mahindra Capital Company Limited.
-
Axis Capital Limited.
-
Hdfc Bank Limited.
-
Motilal Oswal Investment Advisors Limited.
Dividend Policy
The company has not paid any dividends in the last three fiscal.
Conclusion
This can provide an opportunity for many investors to get themselves exposure in the growing Indian health insurance market. In any case, the revenues show an impressive growth trend with extensive product offerings from it. The brand reputation too has been well-established with potential. However, with such losses in recent years, P/E ratios do go up, which signifies there could be some limitations associated with the company.
Finowings IPO Analysis
Hope you enjoyed the Finowings IPO Analysis. We tried our best to give every required detail about the company that you should know before applying to the IPO.
You must consult your financial advisor before making any financial decisions.
To Apply for the IPO, Click Here.
To Read the Prospectus of the Company Click Here to Download the DRHP.
DISCLAIMER:
This blog is NOT any buy or sell recommendation. No trading advice/suggestion is given. The content is purely for educational and information purposes only. Always consult your eligible financial advisor for investment-related decisions.
Click Here to stay updated with the Upcoming IPOs.
Want to start Your Journey in stock market trading and investment? Join our Stock Market Class to become a beginner to expert trader! We cover everything from the basics of trading to advanced strategies for picking stocks. Plus, we're offering a special discount for women and students. Don't miss out - enroll now and kickstart your path to success in the stock market! Open a world of Stock Market by Opening a Demat Account with your favorite Broking firm & Get a trading Strategy worth Rs.15,000!
Click here to open a Free Demat Account.
Thank You for reading this blog.Hope you loved the IPO analysis. Please Comment Below with your feedback because Your feedback motivates us to deliver more such content.
Follow MUKUL AGRAWAL for the latest IPO news and reviews. You can connect with us on social media platforms like Twitter, Facebook, and Instagram. You can also subscribe to our YouTube Channel for the latest videos of the stock.
Frequently Asked Questions
It is the joint venture of Bupa Group and Fettle Tone LLP.
Krishnan Ramachandran is the CEO of the company.
Rs.26,628 million as of FY 2023.
16.24% as of FY2024.
The claim settlement ratio of the company is 99.99.